Arch Biopartners Inc.
ARCH.V
TSX
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | 2.50% | -276.09% | 75.80% | 72.90% | 54.89% |
| Total Depreciation and Amortization | -- | -- | -- | -- | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 1,944.10% | 246.36% | -98.15% | 1,626.85% | -103.41% |
| Change in Net Operating Assets | -- | -- | -- | -- | -- |
| Cash from Operations | 80.59% | 5.49% | 45.66% | 113.02% | -5.54% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | 178.39% | -93.58% | 196.94% | -- | -52.80% |
| Total Debt Repaid | -- | -- | -- | -44.17% | -- |
| Issuance of Common Stock | -6.16% | 137.70% | -- | -61.18% | 193.45% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 5.31% | -10.42% | -78.63% | -95.20% | 131.04% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 1,097.12% | -95.96% | -300.33% | 316.85% | 85.79% |